Literature DB >> 3815504

Hemodynamic correlates of arterial compliance.

J J Ferguson, O S Randall.   

Abstract

There is at present no good understanding of the exact clinical correlates of arterial compliance. The purpose of this study was to establish which hemodynamic variables are most strongly associated with compliance. Hemodynamic measurements were performed on 41 patients undergoing diagnostic cardiac catheterization. Cardiac outputs were determined by thermodilution, and pressures were measured in the ascending aorta with a catheter-tip manometer. Compliance was calculated from a mono-exponential fit of diastolic decay pressures. Pulse pressure(PP), stroke volume(SV), age, systolic blood pressure(SBP), and cardiac output(CO) were significantly related to compliance. The quotient SV/PP was a good estimate of compliance, as was a first-order function of both SV and PP. There appear to be specific clinical correlates of arterial compliance, as well as ways to estimate arterial compliance on the basis of conventional hemodynamic measurements when direct calculations are not possible.

Entities:  

Mesh:

Year:  1986        PMID: 3815504     DOI: 10.1002/ccd.1810120604

Source DB:  PubMed          Journal:  Cathet Cardiovasc Diagn        ISSN: 0098-6569


  11 in total

1.  Associations between echocardiographic arterial compliance and incident cardiovascular disease in blacks: the ARIC study.

Authors:  Melissa C Caughey; Laura R Loehr; Susan Cheng; Scott D Solomon; Christy Avery; Alan L Hinderliter
Journal:  Am J Hypertens       Date:  2014-05-18       Impact factor: 2.689

2.  Regional aortic compliance studied by magnetic resonance imaging: the effects of age, training, and coronary artery disease.

Authors:  R H Mohiaddin; S R Underwood; H G Bogren; D N Firmin; R H Klipstein; R S Rees; D B Longmore
Journal:  Br Heart J       Date:  1989-08

3.  Obesity and Cardiovascular Diseases in a High-Risk Population: Evidence-Based Approach to CHD Risk Reduction.

Authors:  John Kwagyan; Tamrat M Retta; Muluemebet Ketete; Cristina N Bettencourt; Abid R Maqbool; Shichen Xu; Otelio S Randall
Journal:  Ethn Dis       Date:  2015       Impact factor: 1.847

4.  Flow resistance and its components in hypertensive men treated with the calcium antagonist isradipine.

Authors:  M Wysocki; B Persson; U Bagge; O K Andersson
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 5.  Elastic properties and Windkessel function of the human aorta.

Authors:  G G Belz
Journal:  Cardiovasc Drugs Ther       Date:  1995-02       Impact factor: 3.727

6.  Dynamic arterial elastance to predict arterial pressure response to volume loading in preload-dependent patients.

Authors:  Manuel Ignacio Monge García; Anselmo Gil Cano; Manuel Gracia Romero
Journal:  Crit Care       Date:  2011-01-12       Impact factor: 9.097

7.  Pulsatile operation of a continuous-flow right ventricular assist device (RVAD) to improve vascular pulsatility.

Authors:  Boon C Ng; Matthias Kleinheyer; Peter A Smith; Daniel Timms; William E Cohn; Einly Lim
Journal:  PLoS One       Date:  2018-04-20       Impact factor: 3.240

8.  Effect of diet and exercise on pulse pressure and cardiac function in morbid obesity: analysis of 24-hour ambulatory blood pressure.

Authors:  Otelio S Randall; John Kwagyan; Zhenqui Huang; Shichen Xu; Muluemebet Ketete; Abid R Maqbool
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-08       Impact factor: 3.738

9.  Effect of intensive blood pressure control on cardiovascular remodeling in hypertensive patients with nephrosclerosis.

Authors:  Otelio Randall; John Kwagyan; Tamrat Retta; Kenneth Jamerson; Velvie Pogue; Keith Norris; Muluemebet Ketete; Shichen Xu; Tom Greene; Xuelei Wang; Lawrence Agodoa
Journal:  Int J Nephrol       Date:  2013-09-11

10.  Impact of arterial load on the agreement between pulse pressure analysis and esophageal Doppler.

Authors:  Manuel Ignacio Monge García; Manuel Gracia Romero; Anselmo Gil Cano; Andrew Rhodes; Robert Michael Grounds; Maurizio Cecconi
Journal:  Crit Care       Date:  2013-06-20       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.